Use of danaparoid sodium (Orgaran®) as an alternative to heparin sodium during cardiopulmonary bypass: a clinical evaluation of six cases

Abstract

Heparin-induced thrombocytopenia (HIT) has become more prevalent in today’s cardiac setting and has resulted in the need for alternative anticoagulant therapies.

Danaparoid sodium, one alternative to heparin, has been used in six cardiopulmonary bypass procedures in this hospital. This clinical experience has resulted in the progressive refinement of a protocol for the ‘safe’ clinical use of danaparoid sodium.

Although there were six positive outcomes with the use of danaparoid sodium, alternatives must be explored in order to find the optimal anticoagulant for the treatment of HIT.

Get full access to this article

View all access options for this article.

References

Shorten GD , Communale ME. Heparin-induced thrombocytopenia . J Cardiothorac Vasc Anesth 1996; 10: 521-530 .

Wilhelm MJ , Schmid C , Kececioghi D et al. Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia using Orgaran® 10172 . Ann Thorac Surg 1996; 61: 920-924 .

Ortel TL , Chong BH. New treatment options for heparin-induced thrombocytopenia . Semin Hematol 1998; 35 (4 Suppl. 5): 26-34 .

Magnani HN , Beijering RJR , Ten Cati JW et al. Orgaran anticoagulation for cardiopulmonary bypass in patients with heparin-induced thrombocytopenia. Reprinted from Roque Pifarre ed. New anticoagulants for the cardiovascular patient. Philadelphia, PA: Hanley & Belfus , 1997: 487-500.

Doherty DC , Ortel TL , DeBruijn N et al. ‘Heparin-free’ cardiopulmonary bypass: first reported use of heparinoid (Org. 10172) to provide anticoagulation for cardiopulmonary bypass . Anesthesiology 1990; 73: 562-565 .

Ramakrishna R , Manoharan A , Kwan UL et al. Heparin-induced thrombocytopenia: cross-reactivity between standard heparin, low molecular weight heparin, daltepauin (Fragmin) and heparinoid, danaparoid (Orgaran) . Br J Haematol 1995; 91: 736-738 .

Gillis S , Merin G , Zahger D et al. Danaparoid for cardiopulmonary bypass in patients with previous heparin-induced thrombocytopenia . Br J Haematol 1997; 98: 657-659 .